Showing results (161-170 of 198) with videos related to
Sort By:
Pageof 20
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
The discovery of orally available thrombin inhibitors: optimisation of the P1 pharmacophoreJ Ambler, D Bentley, L Brown, et al.Endocrine-Related Cancer|December 2, 2010
Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?D Deandreis, A Al Ghuzlan, S Leboulleux, et al.Research Square|November 6, 2024
Marketing for Sensa: A novel "zero nicotine vapor product" from a major tobacco companyMeagan O Robichaud, Eugene M Talbot, Ollie Ganz, et al.Journal of the National Cancer Institute|September 4, 1996
Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinomaJ Bourhis, R Lubin, B Roche, et al.Tobacco Control|March 23, 2023
IQOS print magazine advertising characteristics and reach before and after FDA authorisation as a modified risk tobacco productOllie Ganz, Andrew A Strasser, Daniel P Giovenco, et al.Peerj|August 5, 2024
Metagenome-wide characterization of shared antimicrobial resistance genes in sympatric people and lemurs in rural MadagascarBrooke M Talbot, Julie A Clennon, Miarintsoa Fara Nantenaina Rakotoarison, et al.Environmental Microbiology Reports|August 4, 2017
Methanotroph-derived bacteriohopanepolyol signatures as a function of temperature related growth, survival, cell death and preservation in the geological recordKate A Osborne, Neil D Gray, Angela Sherry, et al.Circulation|June 14, 2000
Predictors of systolic augmentation from left ventricular preexcitation in patients with dilated cardiomyopathy and intraventricular conduction delayG S Nelson, C W Curry, B T Wyman, et al.Oncogene|August 16, 2011
ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescenceU Weyemi, O Lagente-Chevallier, M Boufraqech, et al.La Revue De Medecine Interne|November 2, 2019
[Bilateral adrenal hemorrhage under apixaban in primary antiphospholipid syndrome]V Lavoipierre, M Talbot, C Soubrier, et al.Pageof 20